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Objective: To investigate the effects of the F protein of Hepatitis
C virus subtype 1b on the apoptosis of human hepatocellular
carcinom HepG2 cells.
Methods: HepG2 cells were transfected with recombinant plas-
mid pcDNA3.0-F-EGFP. And pcDNA3.0-F-EGFP-HepG2 strain was
exposed to Actinomycin D and tumor necrosis factor α treatment
to induce cell apoptosis with positive control pcDNA3.0-C-EGFP-
HepG2, negative control pcDNA3.0-C-EGFP-HepG2 and blank con-
trol HepG2. Annexin V-FITC/PI of Flow cytometry was performed
to determine the number of apoptotic cells. DNA Ladder was
used to observe the isolation of apoptotic DNA fragments in the
apoptotic cells.
Results: pcDNA3.0-F-EGFP- HepG2 cell strain showed a much
delayed apoptosis as well as obviously lowered apoptotic rate
in comparison with the pcDNA3.0-HepG2 strain and HepG2 strain
(P<0.001).
Fig. 1. Apoptosis of HepG2 cells in four groups treated for 48 hours with
Act-D, TNFα. I. Apoptosis of HepG2 of F group, 62.44%; II. Apoptosis of
HepG2 of C group, 48.7%; III. Apoptosis of HepG2 of Negative group, 95.3%;
IV. Apoptosis of HepG2 of Blank control group, 94.52%.
Fig. 2. Temporal changes of the cell apoptotic rate in four groups. Mean
values of the four groups for each condition and standard deviations are
shown.
Conclusion: The F gene of Hepatitis C virus subtype 1b signiﬁ-
cantly inhibits the apoptosis of HepG2 cells.
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Objectives: To demonstrate the role of HCV-F (Hepatitis C virus)
protein on the pathogenic mechanism of chronic hepatitis C,
especially on cell signal pathway.
Methods: PBMCs (peripheral blood mononuclear cells) from
twenty-eight HCV infected patients and ten healthy volunteers
were separated. The total proteins were quantitated by BradFord
assay and separated by the immobilized pH gradient-based 2-DE.
The differentially expressed proteins were screened by PDQuest
analysis software. PMF (peptide mass ﬁngerprint) was obtained
by MALDI-TOF-MS (matrix-assisted laser desorption/ionization
time of ﬂight mass spectrometry). Proteins were identiﬁed by
searching SWISS-PROT. The recombinant vector pcDNA3.0(–)-F
containing F gene and the control vector pcDNA3.0(–) were
transfected into HepG2 cells using Lipofectamin2000. Then RT-
PCR and Western blot analysis were performed.
Results: 2-DE results showed that the mean number of protein
spots in HCV infected patients and healthy persons were 625
and 614, respectively (Fig. 1). Twelve differential proteins were
tested by MALDI-TOF-MS, and ten of them were identiﬁed includ-
ing HCV-F protein and some proteins participated in cell signal
pathway. HCV-F protein was successfully expressed in HepG2
cells. Meanwhile, the expression of PI3K protein was detected in
a high level in the pcDNA3.0(–)-F infected HepG2 cells (Fig. 2).
Conclusion: The expression of HCV-F protein in infected cells has
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